Additional CHMP Positive Opinions
This article was originally published in The Pink Sheet Daily
Executive Summary
The European agency also gave positive reviews for another half dozen products, including Provenge for asymptomatic or minimally symptomatic metastatic prostate cancer, and Lemtrada and Aubagio for MS.